NanoString Technologies, Inc.
MOLECULAR GENE SIGNATURES AND METHODS OF USING SAME
Last updated:
Abstract:
The invention provides methods of using expression levels of one or more cell gene signatures and/or combinations of cell gene signatures as selection criteria for selecting a patient having a cancer for treatment with a therapeutic. The invention further provides methods for selecting a patient having cancer who may benefit from a particular therapeutic, such as an immunotherapy and administering to the patient the immunotherapy to treat the cancer.
Status:
Application
Type:
Utility
Filling date:
20 May 2019
Issue date:
25 Nov 2021